# Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

> **NCT00152503** · PHASE2 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 59 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Seletracetam (UCB44212)

## Key facts

- **NCT ID:** NCT00152503
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08-31
- **Primary completion:** 2006-05-12
- **Final completion:** 2006-05-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152503, "Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00152503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*